2018
DOI: 10.1097/md.0000000000012985
|View full text |Cite
|
Sign up to set email alerts
|

Successful low-dosage thrombolysis of massive pulmonary embolism in primigravida

Abstract: Rational:Thrombolysis in primigravida with hemodynamic instability is controversial, especially treatment with low-dosage recombinant tissue plasminogen activator (rtPA), and related studies are extremely rare. Here, we report the case of a 26-year-old primigravida diagnosed with an acute massive pulmonary embolism (PE) that prompted initiation of thrombolysis with low-dose alteplase.Patient concerns:The patient was admitted to the Emergency Department with chief complaints of a sudden onset of extremely dyspn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…It is therefore not surprising that very low doses of thrombolytic therapy were effective in restoring pulmonary perfusion and preventing right heart collapse. 29,30 Highly reduced-dose thrombolysis for acute PE has been successfully used in high bleeding risk situations, for example, in post-surgical or pregnant patients, [31][32][33][34][35] indicating that the low-dose thrombolysis for PE is associated with reduced bleeding risk, while maintaining some efficacy in restoring pulmonary blood flow.…”
Section: Introductionmentioning
confidence: 99%
“…It is therefore not surprising that very low doses of thrombolytic therapy were effective in restoring pulmonary perfusion and preventing right heart collapse. 29,30 Highly reduced-dose thrombolysis for acute PE has been successfully used in high bleeding risk situations, for example, in post-surgical or pregnant patients, [31][32][33][34][35] indicating that the low-dose thrombolysis for PE is associated with reduced bleeding risk, while maintaining some efficacy in restoring pulmonary blood flow.…”
Section: Introductionmentioning
confidence: 99%